NCT02927769 · Interventional trial
A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment
Overall registry status Completed
Phase 2
Conditions Hodgkin Disease
Delaware Valley sites
- Childrens Hospital Of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory